Sjögren Syndrome
📧 Sign up to get email alerts when something new happens for Sjögren Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases [Phase 1]
Phase 1 clinical trial evaluating the safety of CD19-targeted CAR-T cell therapy produced at Gustave Roussy for adults with severe and refra…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of IMVT-1402 in adults with moderate to severe systemic Primary Sjögren's disease …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study
A 3-month longitudinal clinical trial from Kahramanmaras Sutcu Imam University aims to identify factors and predictors of fatigue in patient…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease [Phase 3]
Phase 3 study of Telitacicept in active primary Sjögren's syndrome is currentlyRecruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Characterization of Diseases With Salivary Gland Involvement
The National Institute of Dental and Craniofacial Research is conducting a study to characterize diseases with salivary gland involvement, w…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Pathogenesis and Natural History of Sjogren's Disease
This clinical trial aims to investigate the pathogenesis and natural history of Sjögren's syndrome and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of efgartigimod in patients with Primary Sjögren's syndrome. The study is spo…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: MTS109 in Patients With Refractory Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 clinical trial evaluating MTS109 in adults with refractory autoimmune diseases is currently recruiting. The study includes systemi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Patient-Centered Assessment of Symptoms and Outcomes
NCCIH-sponsored clinical trial update describes a study on patient-centered assessment of symptoms and outcomes for fatigue and cancer, curr…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of BEN301 Injection in theTreatment of Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 study of BEN301 Injection for multiple autoimmune diseases is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Nipocalimab in Moderate to Severe Sjogren's Disease [Phase 3]
Phase 3 study of Nipocalimab for moderate to severe Sjögren's syndrome is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of BEN301 Injection in the Treatment of Autoimmune Diseases [EARLY_Phase 1]
Early Phase 1 clinical trial update for BEN301 injection evaluating safety in autoimmune diseases including systemic sclerosis, rheumatoid a…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) [Phase 3]
This document describes a long-term extension Phase 3 trial of dazodalibep for Sjögren's syndrome, sponsored by Amgen, which is currently re…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) [Phase 1]
Phase 1 trial update evaluating intravenous ABBV-319 in adults with systemic lupus erythematosus and Sjögren's syndrome, focusing on adverse…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome [Phase 3]
Phase 3 study evaluating deucravacitinib in adults with active Sjögren's syndrome; the trial is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating safety, cellular kinetics, and exploratory efficacy of Rapcabtagene Autoleucel in rheumatoid art…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies [NA]
A clinical trial update indicates recruitment for a Sjögren's syndrome study evaluating fatigue across three therapeutic strategies.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. [Phase 3]
A Phase 3 extension study (NEPTUNUS) evaluates long-term safety and efficacy of ianalumab in patients with Sjögren's syndrome; the trial is …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Managed Access Programs for VAY736, Ianalumab
Clinical trial update indicating that managed access programs exist for the investigational antibody ianalumab (VAY736) from Novartis, for p…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's [Phase 2]
Phase 2 clinical trial evaluating subcutaneous Sibeprenlimab in Sjögren's syndrome; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome [Phase 3]
Phase 3 trial evaluating Ianalumab (VAY736) in active Sjögren's syndrome is ongoing but not currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE [Phase 4]
A Phase 4 clinical trial assessing the effectiveness of CO2-laser treatment versus topical promestriene for vaginal dryness in Sjögren's syn…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…